HYPD
Hyperion Defi Inc
NASDAQ · Pharmaceuticals
$4.14
+0.68 (+19.65%)
Open$3.58
Previous Close$3.46
Day High$4.54
Day Low$3.50
52W High$15.79
52W Low$6.60
Volume—
Avg Volume676.3K
Market Cap33.83M
P/E Ratio21.74
EPS$0.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+289.9% upside
Current
$4.14
$4.14
Target
$16.14
$16.14
$9.68
$16.14 avg
$20.98
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.38M | 5.01M | 5.20M |
| Net Income | 1.66M | 1.46M | 1.25M |
| Profit Margin | 30.8% | 29.2% | 24.0% |
| EBITDA | 2.19M | 1.99M | 2.29M |
| Free Cash Flow | 1.17M | 1.60M | 1.59M |
| Rev Growth | +23.3% | +22.0% | +7.9% |
| Debt/Equity | 0.42 | 0.45 | 0.53 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |